Vortioxetine hydrobromide Catalog No.:M10128-10 Need ultrasonic) H2O : 5

Need ultrasonic) H2O : 5 mg/mL (15

WZ-3146 was identified by screening an irreversible kinase inhibitor library specifically against EGFR T790M

also called L235

InChiKey: KWJRSHZSULRJHE-UHFFFAOYSA-N

Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation

Vortioxetine hydrobromide Catalog No.:M10128-10 Need ultrasonic) H2O : 5Vortioxetine, also known as Lu AA21004, is an atypical antidepressant, and was approved in 2013 by the U. S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a so called "serotonin modulator and stimulator." It has been shown to possess the following pharmacological actions: Serotonin transporter (SERT) blocker (i. e. serotonin reuptake inhibitor (SRI)) Ki (binding affinity) = 1. 6 nM, IC50 = 5. 4 nM; Norepinephrine